AvKARE has voluntarily recalled 153 cartons of Atovaquone Oral Suspension USP, 750 mg per 5 mL, due to potential contamination with Bacillus cereus bacteria. This prescription medication is used to treat or prevent certain types of pneumonia and is packaged in cartons containing 20 individual 5 mL sachets. No illnesses or injuries have been reported to date in connection with this recall.
The product may be contaminated with Bacillus cereus, which can cause food poisoning symptoms such as abdominal pain, diarrhea, nausea, and vomiting. In patients with weakened immune systems, this bacterial contamination could lead to more serious or life-threatening infections.
You have 2 options:
Quantity: 153 cartons.
Image 2 – Product labeling, sachet, Atovaquone Oral Suspension USP
Image 1 – Product labeling, Atovaquone Oral Suspension, USP
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.